Numerous Cell and Gene Therapy (CGT) companies have chosen to locate their biomanufacturing operations here in North Carolina. At this time of exciting growth and discovery in the CGT field, BPD’s 5th Cell and Gene Therapy Symposium and Vendor Show will be held Friday, April 25, 2024 at the UNC Friday Conference Center in Chapel Hill, NC. Come find out more about the field by registering to attend this very affordable, full day Cell and Gene Therapy event (the only one of its kind in North Carolina!). Come learn about technical advances and challenges in this field from speakers, as well as what suppliers and service providers can offer to support your CGT process and product development projects.

Agenda

8:00 – 9:00 a.m. | Attendee Check-In/Registration

9:00 – 9:05 a.m. | Opening of Symposium and Welcome by Platinum Sponsor: Kymanox

9:05 – 10:20 a.m. | Speaker Session I

9:05 – 9:10 a.m. | Speaker Introductions

9:10 – 9:45 a.m. | “FDA’s latest guidance: Everything You Always Wanted to Know About Cell and Gene Therapy Development, But Were Too Afraid to Ask” – Maria Oyaski, MS, MA, RAC (US, EU); Consulting Regulatory Scientist, Oyaski Regulatory Consulting

9:45 – 10:20 a.m. | “Viral Vector Manufacturing: The Decision for Fed-batch vs. Continuous Biomanufacturing” – Jeff Odum, BS, MS, CPIP; SME, NC Biosource

10:20 – 11:00 a.m. | Morning Break, Visit Sponsor and Vendor Tables, and enjoy Networking

11:00 – 12:15 a.m. | Speaker Session II

11:00 – 11:05 a.m. | Speaker Introductions

11:05 – 11:40 a.m. | “How to Measure Potency: Strategies, Challenges, and Real-World Solutions for Cell & Gene Therapies” – Joseph Newcome, MS; Senior Director, Analytical Method Development, WuXi Advanced Therapies

11:40 – 12:15 p.m. | “Shaping the Future of Cell and Gene Therapy with AI and Machine Learning” – Robin Newman, B.S. Chemical Engineering, EIT; Project Manager, Amgen

12:15 – 1:45 p.m. | Lunch Break, Visit Sponsor and Vendor Tables, and enjoy Networking

1:45 – 3:05 p.m. | Speaker Session III

1:45 – 1:55 p.m. | Announcements and Speaker introductions

1:55 – 2:30 p.m. | “Cell Therapy Manufacturing Ramp-Up Case Study” – Stephen Lane; Industrial Analyst II: Modeling & Simulation and George Todorov, Senior Process Specialist, GST; IPS – Integrated Project Services

2:30 – 3:05 p.m. | “Novel Analytical Technologies for Cell and Gene Therapy” – Scott R. Burger, MD; Principal Consultant, Advanced Cell & Gene Therapy

3:05 – 3:45 p.m. | Afternoon Break, Visit Sponsor and Vendor Tables, and enjoy Networking

3:45 – 5:00 p.m. | Speaker Session IV

3:45 – 3:50 p.m. | Speaker Introductions

3:50 – 4:25 p.m. | “Differential Replication and Rescue of scAAV vs. ssAAV Vectors and Impact on Residual Plasmid DNA Impurities” – Chunping Qiao, PhD; Associate Director, Novartis

4:25 – 5:00p.m. | “Automating PAT models for Continuous Process Verification” – Bruce Greenwald; DeltaV Business Development Director, Emerson

5:00 – 5:05 p.m. | Thank you to Organizers, Sponsors, Vendors, and Attendees

(Exit by 5:30p.m.)

Platinum Sponsor: Kymanox

Gold Sponsors: ABEC, Aldevron, Appeture Solutions, Charles River, Cytiva, Millipore Sigma

Silver Sponsors: Beckman Coulter Life Sciences, Bio-Techne, Eppendorf Bioprocess, IPS-Integrated Project Services, Isolere Bio, KACTUS, Kincell Bio, ProAnalytics LLC, SCIEX, Sepax Bioscience, STERIS, WuXi Advanced Therapies

Participating Vendors:

ACGT, ACROBiosystems, Akron Bio, Astrea Bioseparations, Biologos, Carolina Components Group, Contec, Inc., Corning Life Sciences, Cygnus Technologies, Dagard USA, GENEWIZ by Azenta Life Sciences, Omega Bio-tek, Proteintech, Refeyn, Repligen, SaniSure, Sartorius Stedim North America Inc., Scinomix, Inc., Sharp Sterile Manufacturing, Solvias, Unchained Labs, Univercells Technologies, Waters Corporation